• Register
  • Login
  • Subscribe
  • Contact Us

Latest Antineoplastic Tenders in Jordan 2025

JordanTenders brings you the latest and most relevant Antineoplastic tenders in Jordan, sourced directly from reliable government portals, purchaser websites, and leading procurement publications. Whether you're a supplier, contractor, or manufacturer, we ensure you stay informed about ongoing bidding opportunities without missing a beat.

Our platform is regularly updated with tenders related to Antineoplastic and other keywords tenders. Each listing includes key details such as tender reference numbers, submission deadlines, and purchaser information helping you make informed bidding decisions quickly and confidently.

By subscribing to JordanTenders, users gain unlimited access to public procurement notices related to Antineoplastic. Our tools also offer category-based filtering, email alerts, and quick tender downloads, making your bidding process faster and more efficient. Stay ahead of the competition and grow your business by exploring verified tenders from both government and private entities across Jordan.

Re-Offering a Tender for Immunology and Cancer Medicines in 2024

JOT Ref No.:  105743188

Deadline:  19 Aug 2024

Re-Offering a Tender for Immunology and Cancer Medicines in 2024

JOT Ref No.:  105127636

Deadline:  12 Aug 2024

Re-Offering a Tender for Immunology and Cancer Medicines in 2024

JOT Ref No.:  105063007

Deadline:  12 Aug 2024

Tender for Immunology and Cancer Medicines 2024

JOT Ref No.:  104710082

Deadline:  29 Jul 2024

Tender for Immunology and Cancer Medicines 2024

JOT Ref No.:  104289361

Deadline:  29 Jul 2024

Tender for Immunology and Cancer Medicines 2024

JOT Ref No.:  103147718

Deadline:  29 Jul 2024

Giving Immunity and Cancer 2024

JOT Ref No.:  101933469

Deadline:  01 Jul 2024

Immunomodulator and Antineoplastic Drug

JOT Ref No.:  91033696

Deadline:  06 Nov 2023

Sub Solicitation - Immunomodulator and Antineoplastic Drug

JOT Ref No.:  88910204

Deadline:  02 Oct 2023

Immunomodulator and Antineoplastic Drug

JOT Ref No.:  85628023

Deadline:  31 Jul 2023

  Chat with us